Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Cancer immunotherapy: Targeting the difference
Sarene Koh, Antonio Bertoletti
Immunology and Immunotherapy
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Citations (Scopus)
188
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cancer immunotherapy: Targeting the difference'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Tumor-infiltrating Lymphocytes
100%
T Helper 1
100%
Epithelial Cancer
100%
Mutation Specific
100%
Cancer Immunotherapy
100%
Disease Progression
50%
Interacting Proteins
50%
CD4+ T
50%
Adoptive Transfer
50%
ErbB2
50%
Absence of Evidence
50%
Tumor Regression
50%
CD4+ T Cell Response
50%
Antigen-specific T Cell Response
50%
Polyfunctional
50%
Metastatic Cholangiocarcinoma
50%
Mutated Antigen
50%
Target Lesion
50%
Exomics
50%
Medicine and Dentistry
Malignant Neoplasm
100%
Cancer Immunotherapy
100%
T Helper 1 Cell
100%
T-Cell Response
66%
Tumor Infiltrating Lymphocyte
66%
Disease
33%
Disease Exacerbation
33%
T-Helper Cell
33%
Adoptive Transfer
33%
Tumor Regression
33%
Cholangiocarcinoma
33%
Target Lesion
33%
Immunology and Microbiology
T Helper 1 Cell
100%
Cancer Immunotherapy
100%
Tumor-Infiltrating Lymphocytes
66%
T Cell
33%
T-Helper Cell
33%
CD4
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Immunotherapy
100%
Neoplasm
50%
Disease
25%
Disease Exacerbation
25%
Tumor Regression
25%
Bile Duct Carcinoma
25%